Asthma and allergy

Physical activity end-points in trials of chronic respiratory diseases: summary of evidence
Cassie Rist, Niklas Karlsson, Sofia Necander, Carla A. Da Silva

ERJ Open Research Jan 2022, 8 (1) 00541-2021; DOI: 10.1183/23120541.00541-2021
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
Yochai Adir, Einat Fireman Klein, Walid Saliba

ERJ Open Research Jan 2022, 8 (1) 00014-2022; DOI: 10.1183/23120541.00014-2022
Human bronchial epithelial cells from patients with asthma have an altered gene expression profile
Sangita Bhaker, Michael A. Portelli, Kamini Rakkar, Dominick Shaw, Simon Johnson, Christopher Brightling, Ian Sayers

ERJ Open Research Jan 2022, 8 (1) 00625-2021; DOI: 10.1183/23120541.00625-2021
Vitamin D supplementation in childhood asthma: a systematic review and meta-analysis of randomised controlled trials
Jogender Kumar, Prawin Kumar, Jagdish Prasad Goyal, Chirag Thakur, Puja Choudhary, Jitendra Meena, Jaykaran Charan, Kuldeep Singh, Atul Gupta

ERJ Open Research Jan 2022, 8 (1) 00662-2021; DOI: 10.1183/23120541.00662-2021
De-labelling severe asthma diagnosis: the challenge of DIPNECH
Caroline Hurabielle, Camille Taillé, Grégoire Prévot, Maud Russier, Alain Didier, Pierre-Olivier Girodet, Magali Colombat, Julien Mazières, Laurent Guilleminault

ERJ Open Research Jan 2022, 8 (1) 00485-2021; DOI: 10.1183/23120541.00485-2021
Observational study of inhaled corticosteroid treatment for improved expiratory variability index in steroid-naïve asthmatic children
Janne Burman, Pekka Malmberg, Ville-Pekka Seppä, Tuomas Jartti, Sami Remes, Ove Mickelsson, Anna S. Pelkonen, Mika J. Mäkelä

ERJ Open Research Jan 2022, 8 (1) 00499-2021; DOI: 10.1183/23120541.00499-2021
Missing sputum samples are common in asthma intervention studies and successful collection at follow-up is related to improvement in clinical outcomes
Laurits Frøssing, Morten Hvidtfeldt, Alexander Silberbrandt, Asger Sverrild, Celeste Porsbjerg

ERJ Open Research Jan 2022, 8 (1) 00612-2021; DOI: 10.1183/23120541.00612-2021
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
Simon Couillard, William Il Hoon Do, Richard Beasley, Timothy S.C. Hinks, Ian D. Pavord

ERJ Open Research Jan 2022, 8 (1) 00570-2021; DOI: 10.1183/23120541.00570-2021
Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET
Mark C. Liu, Elisabeth H. Bel, Oliver Kornmann, Wendy C. Moore, Norihiro Kaneko, Steven G. Smith, Neil Martin, Robert G. Price, Steven W. Yancey, Marc Humbert

ERJ Open Research Jan 2022, 8 (1) 00419-2021; DOI: 10.1183/23120541.00419-2021
Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study
Elizabeth Benz, Sara R.A. Wijnant, Katerina Trajanoska, Johnmary T. Arinze, Emmely W. de Roos, Maria de Ridder, Ross Williams, Frank van Rooij, Katia M.C. Verhamme, M. Arfan Ikram, Bruno H. Stricker, Fernando Rivadeneira, Lies Lahousse, Guy G. Brusselle

ERJ Open Research Jan 2022, 8 (1) 00628-2021; DOI: 10.1183/23120541.00628-2021

Main menu

User menu

Search

Asthma and allergy

Pages

Contact us